How to Evidence ROI in a Digital Pathway Transformation
April 27, 2026
.svg)
July 23, 2026
Skin cancer is one of the most common cancers in the UK, and incidence continues to rise.
For healthcare systems already managing growing demand, workforce shortages and significant elective backlogs, this presents a difficult challenge. Every suspected skin cancer referral must be assessed quickly and appropriately. Yet dermatology services across the NHS remain under considerable pressure, with increasing referral volumes competing for limited specialist capacity.
In this environment, referral delays are more than an operational issue. They have direct implications for patient outcomes, clinical risk and patient experience.
The challenge facing NHS organisations is not simply how to process more referrals. It is how to ensure that the right patients are identified, prioritised and managed as early as possible. This is where digital dermatology pathways and structured specialist advice become increasingly important.
Demand for dermatology services has increased significantly over the past decade. An ageing population, greater public awareness of skin cancer symptoms and rising incidence rates have all contributed to growing referral volumes.
At the same time, skin lesions remain one of the most common reasons patients present to General Practice. Many lesions are benign, but distinguishing between benign and potentially malignant conditions can be challenging, particularly in time-pressured primary care settings. The result is a difficult balancing act.
Clinicians need to ensure that patients with suspected melanoma, squamous cell carcinoma or other serious skin cancers are identified rapidly. Yet services must also avoid overwhelming specialist clinics with referrals that could be managed differently.
Without efficient referral pathways, both groups of patients can experience delays.
Patients with benign conditions may wait unnecessarily for reassurance and treatment. More importantly, patients with genuine skin cancers may face longer waits for diagnosis and intervention.
When discussing referral delays, it is tempting to focus solely on waiting list performance metrics. However, the impact on patients is often far more significant.
For patients with suspected skin cancer, uncertainty can be extremely distressing. The period between referral and specialist assessment is often characterised by anxiety, repeated GP consultations and ongoing concerns about disease progression.
For clinicians, delays can create additional workload and uncertainty. Primary care teams may need to manage repeat appointments, respond to patient concerns and monitor conditions while waiting for specialist input.
Most importantly, delays can affect clinical outcomes.
While not every skin lesion represents an urgent cancer diagnosis, earlier identification and treatment remain central principles of effective cancer care. Rapid assessment enables appropriate intervention and helps ensure that patients are directed towards the most suitable pathway as quickly as possible.
The challenge for healthcare systems is therefore not simply reducing waiting times. It is creating pathways that accelerate clinical decision-making from the earliest possible stage.
Historically, many dermatology referrals have followed a relatively straightforward process. A patient presents to primary care. The clinician assesses the lesion and submits a referral. The patient then waits for specialist review before the next stage of management can be determined.
While this model remains appropriate in some circumstances, it can create inefficiencies when applied across large referral volumes.
Specialists may receive referrals that lack sufficient clinical information or high-quality images, they are left with a choice of aking for more information that can introduce further delays or accept the referral on the understanding that a delay may have significant implications to the patient, however, this occupies clinic capacity. Meanwhile, genuinely urgent cases compete for appointments within already stretched services.
These challenges are not unique to dermatology. However, dermatology is particularly well suited to more collaborative and digitally enabled approaches because visual assessment plays such a central role in diagnosis and triage.
As a result, many NHS organisations are exploring new ways to connect primary and secondary care clinicians earlier in the patient journey.
Advice & Refer is becoming an increasingly important component of modern dermatology pathways. As referral volumes rise and specialist capacity remains under pressure, healthcare organisations are looking for ways to connect primary and secondary care clinicians earlier in the patient journey.
A well-designed dermatology Advice & Refer model enables clinicians to access specialist input quickly, helping ensure that patients with suspected skin cancer are directed to the most appropriate pathway without unnecessary delays.
Rather than relying solely on traditional referrals, clinicians can seek specialist input earlier, sharing structured clinical information and diagnostic images to support decision-making.
This creates opportunities to improve triage, accelerate assessment and ensure that specialist expertise is used where it delivers the greatest value.
Effective dermatology Advice & Refer enables:
The objective is not to reduce referrals indiscriminately. It is to ensure that referrals are appropriate, complete and prioritised correctly from the outset.
When specialist advice is available quickly, decisions can be made earlier and patients can move onto the right pathway sooner.
Dermatology differs from many other specialties because images often form a fundamental part of assessment. The quality of clinical photography can therefore have a significant impact on pathway efficiency.
Poor-quality images frequently create additional work for both referrers and specialists. Additional photographs may be required. Further information requests may be necessary. In some cases, patients may need face-to-face appointments simply because remote assessment is not possible. Each additional step introduces friction into the pathway.
Digital referral platforms that support professional grade, secure image capture and structured information sharing can help address this challenge. By ensuring specialists receive the information they need at the point of referral, services can reduce unnecessary delays and support more efficient decision-making. This is already having an effect by reducing the numbers of cases being rejected or requiring additional images.
For patients with suspected skin cancer, these improvements can be particularly valuable because they enable earlier assessment and prioritisation.
Few specialties are as well positioned to benefit from digital referral pathways as dermatology.
Because skin lesion assessment relies heavily on visual information, clinicians can often obtain meaningful specialist input without waiting for a traditional outpatient appointment. When supported by high-quality clinical images and structured referral information, dermatologists can review cases more efficiently and help determine the most appropriate next step.
This makes dermatology a particularly strong use case for Advice & Refer.
A digital dermatology pathway allows clinicians to seek specialist advice earlier, reducing uncertainty while ensuring patients receive the right level of care. For patients with suspected skin cancer, this can support faster decision-making and more effective prioritisation. For healthcare organisations, it helps ensure valuable specialist capacity is focused where it is needed most.
As NHS services continue to modernise referral pathways, dermatology Advice & Refer models are increasingly being recognised as an important tool for improving patient flow, reducing administrative burden and accelerating access to specialist expertise.
The most effective dermatology pathways focus on referral optimisation rather than referral management alone.
Referral management often focuses on processing demand once it enters the system. Referral optimisation focuses on improving decision-making before and during referral creation.
In practice, this means ensuring that clinicians have access to specialist expertise, structured pathways and appropriate digital tools that help them make informed decisions at the earliest opportunity. The benefits extend beyond individual referrals.
Optimised pathways can improve service capacity, reduce unnecessary variation and create a more consistent experience for both clinicians and patients. They also provide greater visibility into pathway performance, enabling healthcare organisations to identify bottlenecks and opportunities for improvement.
The reality of modern healthcare is that clinicians are managing increasing complexity with finite resources. Any new technology introduced into clinical pathways must therefore reduce friction rather than create it.
The success of dermatology Advice & Refer programmes depends not only on specialist engagement but also on clinician adoption. Systems that require excessive administrative effort, duplicate data entry or disrupt existing workflows are unlikely to achieve sustained use.
Cinapsis focuses on supporting clinicians within existing care pathways, helping ensure that specialist advice is accessible without introducing unnecessary complexity. This is particularly important in dermatology, where timely decisions can have a significant impact on both service efficiency and patient outcomes.
When it comes to suspected skin cancer, time matters.Every stage of the pathway, from initial presentation to specialist assessment, influences patient experience and clinical outcomes. Delays can increase anxiety, create additional workload and place further pressure on already stretched services.
Improving these pathways does not necessarily require more appointments or more clinicians. In many cases, it requires better access to information, earlier specialist collaboration and more efficient referral processes. Digital dermatology pathways offer an opportunity to achieve exactly that.
By enabling earlier decision-making, improving referral quality and supporting rapid access to specialist expertise, healthcare organisations can create pathways that work more effectively for both patients and clinicians.
As demand for dermatology services continues to grow, healthcare systems face increasing pressure to ensure that patients with suspected skin cancer are identified and managed as quickly as possible. Effective skin cancer referral pathways depend on rapid access to specialist expertise, high-quality clinical information and efficient clinical communication. Increasingly, these objectives are being supported through digital Advice & Refer models.
Traditional referral processes alone may not be sufficient to meet these challenges. Earlier access to specialist expertise, better referral information and more efficient communication are becoming essential components of modern dermatology pathways.
Cinapsis helps support this shift by enabling structured clinical collaboration, secure image sharing and faster specialist input within a single digital pathway.
For NHS organisations seeking to improve dermatology referral management, reduce delays and strengthen skin cancer pathways, Advice & Refer offers a practical and scalable approach. By enabling earlier specialist involvement and more informed referral decisions, platforms such as Cinapsis can help ensure patients receive the right care at the right time, while supporting clinicians with faster access to expertise when they need it most.
For patients with suspected skin cancer, that means fewer unnecessary delays and a faster route to the care they need. For clinicians, it means greater confidence in decision-making and better access to specialist expertise when it matters most.
In a specialty where time can make a meaningful difference, creating pathways that support earlier action is no longer simply an operational objective. It is a clinical necessity.
.svg)
